All Stories

  1. Genome‐wide siRNA library screening identifies human host factors that influence the replication of the highly pathogenic H5N1 influenza virus
  2. PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence
  3. A genome-wide CRISPR/Cas9 gene knockout screen identifies immunoglobulin superfamily DCC subclass member 4 as a key host factor that promotes influenza virus endocytosis
  4. Genetic and biological properties of H7N9 avian influenza viruses detected after application of the H7N9 poultry vaccine in China
  5. Viral RNA-binding ability conferred by SUMOylation at PB1 K612 of influenza A virus is essential for viral pathogenesis and transmission
  6. H3N2 avian influenza viruses detected in live poultry markets in China bind to human-type receptors and transmit in guinea pigs and ferrets
  7. A Single-Amino-Acid Substitution at Position 225 in Hemagglutinin Alters the Transmissibility of Eurasian Avian-Like H1N1 Swine Influenza Virus in Guinea Pigs
  8. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response
  9. Host Cellular Protein TRAPPC6AΔ Interacts with Influenza A Virus M2 Protein and Regulates Viral Propagation by Modulating M2 Trafficking
  10. Characterization of Clade 7.2 H5 Avian Influenza Viruses That Continue To Circulate in Chickens in China
  11. Glycine at Position 622 in PB1 Contributes to the Virulence of H5N1 Avian Influenza Virus in Mice
  12. Genetics, Receptor Binding, Replication, and Mammalian Transmission of H4 Avian Influenza Viruses Isolated from Live Poultry Markets in China
  13. Rapid Detection of Subtype H10N8 Influenza Virus by One-Step Reverse Transcription–Loop-Mediated Isothermal Amplification Methods
  14. Genetics, Receptor Binding, and Virulence in Mice of H10N8 Influenza Viruses Isolated from Ducks and Chickens in Live Poultry Markets in China
  15. The vaccine efficacy of recombinant duck enteritis virus expressing secreted E with or without PrM proteins of duck tembusu virus
  16. Avian influenza vaccines against H5N1 ‘bird flu’
  17. H6 Influenza Viruses Pose a Potential Threat to Human Health
  18. The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus
  19. Identification of a linear epitope on the haemagglutinin protein of pandemic A/H1N1 2009 influenza virus using monoclonal antibodies
  20. Development of a Reverse Transcription Loop-Mediated Isothermal Amplification Method for the Rapid Detection of Subtype H7N9 Avian Influenza Virus
  21. Two amino acid residues in ion channel protein M2 and polymerase protein PA contribute to replication difference of H5N1 influenza viruses in mice
  22. A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge
  23. H7N9 Influenza Viruses Are Transmissible in Ferrets by Respiratory Droplet
  24. Complex Reassortment of Multiple Subtypes of Avian Influenza Viruses in Domestic Ducks at the Dongting Lake Region of China
  25. Efficacy of Parainfluenza Virus 5 Mutants Expressing Hemagglutinin from H5N1 Influenza A Virus in Mice
  26. The duck genome and transcriptome provide insight into an avian influenza virus reservoir species
  27. Isolation and characterization of H7N9 viruses from live poultry markets — Implication of the source of current H7N9 infection in humans
  28. Recombinant duck enteritis virus works as a single-dose vaccine in broilers providing rapid protection against H5N1 influenza infection
  29. Co-circulation of pandemic 2009 H1N1, classical swine H1N1 and avian-like swine H1N1 influenza viruses in pigs in China
  30. Protective Efficacy of an H5N1 DNA Vaccine Against Challenge with a Lethal H5N1 Virus in Quail
  31. Phylogenetic and Pathogenic Analyses of Avian Influenza A H5N1 Viruses Isolated from Poultry in Vietnam
  32. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs
  33. Characterization of Immune Responses Induced by Immunization with the HA DNA Vaccines of Two Antigenically Distinctive H5N1 HPAIV Isolates
  34. Human Infection from Avian-like Influenza A (H1N1) Viruses in Pigs, China
  35. Key Molecular Factors in Hemagglutinin and PB2 Contribute to Efficient Transmission of the 2009 H1N1 Pandemic Influenza Virus
  36. Proteomic analysis of the lungs of mice infected with different pathotypes of H5N1 avian influenza viruses
  37. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice
  38. Development of a reverse transcription loop-mediated isothermal amplification method for the rapid detection of avian influenza virus subtype H7
  39. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge
  40. Newcastle Disease Virus-Vectored Rabies Vaccine Is Safe, Highly Immunogenic, and Provides Long-Lasting Protection in Dogs and Cats
  41. Strategies for improving the efficacy of a H6 subtype avian influenza DNA vaccine in chickens
  42. New Avian Influenza Virus (H5N1) in Wild Birds, Qinghai, China
  43. The PA Protein Directly Contributes to the Virulence of H5N1 Avian Influenza Viruses in Domestic Ducks
  44. Dogs are highly susceptible to H5N1 avian influenza virus
  45. A protein chip designed to differentiate visually antibodies in chickens which were infected by four different viruses
  46. Characterization of monoclonal antibodies against Muscovy duck reovirus σB protein
  47. Continued Evolution of H5N1 Influenza Viruses in Wild Birds, Domestic Poultry, and Humans in China from 2004 to 2009
  48. Molecular Basis of Neurovirulence of Flury Rabies Virus Vaccine Strains: Importance of the Polymerase and the Glycoprotein R333Q Mutation
  49. Correlation between polymerase activity and pathogenicity in two duck H5N1 influenza viruses suggests that the polymerase contributes to pathogenicity
  50. Generation and Evaluation of a Newcastle Disease Virus–Based H9 Avian Influenza Live Vaccine
  51. Protective Efficacy of H7 Subtype Avian Influenza DNA Vaccine
  52. Protective Efficacy of the H5 Inactivated Vaccine Against Different Highly Pathogenic H5N1 Avian Influenza Viruses Isolated in China and Vietnam
  53. Identification of Amino Acids in HA and PB2 Critical for the Transmission of H5N1 Avian Influenza Viruses in a Mammalian Host
  54. H5N1 influenza viruses: outbreaks and biological properties
  55. Two genotypes of H1N2 swine influenza viruses appeared among pigs in China
  56. The N-Terminal Region of the PA Subunit of the RNA Polymerase of Influenza A/HongKong/156/97 (H5N1) Influences Promoter Binding
  57. H5N1 avian influenza in China
  58. Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates
  59. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus
  60. Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice
  61. Development and Application of Avian Influenza Vaccines in China
  62. Pathogenicity of Chinese H5N1 highly pathogenic avian influenza viruses in pigeons
  63. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens
  64. Single-amino-acid mutation in the HA alters the recognition of H9N2 influenza virus by a monoclonal antibody
  65. A Single-Amino-Acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice
  66. Epidemiology and Control of H5N1 Avian Influenza in China
  67. A Single-Amino-Acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice
  68. Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice
  69. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector
  70. Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza Viruses
  71. Efficacy of DNA Immunization with F and G Protein Genes of Nipah Virus
  72. Vaccines Developed for H5 Highly Pathogenic Avian Influenza in China
  73. Generating Vesicular Stomatitis Virus Pseudotype Bearing the Severe Acute Respiratory Syndrome Coronavirus Spike Envelope Glycoprotein for Rapid and Safe Neutralization Test or Cell‐Entry Assay
  74. The NS1 Gene Contributes to the Virulence of H5N1 Avian Influenza Viruses
  75. Characterization of An Avian Influenza Virus of Subtype H7N2 Isolated from Chickens in Northern China
  76. The first confirmed human case of avian influenza A (H5N1) in Mainland China
  77. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics
  78. Evolution of H9N2 influenza viruses from domestic poultry in Mainland China
  79. Antigenic and genetic analysis of the H9N2 avian influenza viruses isolated in China
  80. Development and evaluation of candidate influenza a vaccines for pandemic preparedness
  81. Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate
  82. Evaluation of a Genetically Modified Reassortant H5N1 Influenza A Virus Vaccine Candidate Generated by Plasmid-Based Reverse Genetics